Seelos Therapeutics Inc (SEEL)

[kingme123]

Here is the reply you received in Aug when you brought this up the first time.Your post was on 08/05/13
value1008 Member Level Monday, 08/05/13 10:52:28 PM
Re: PZLazlo post# 8671



Post # of 11744






Here's from an independent urologists' publication:


http://urologytimes.modernmedicine.com/node/371953
"The leading news source for urologists"

Urology Product Preview
July 29, 2013

ED agent shows efficacy in men unresponsive to PDE-5 inhibitors

Phase III data for Vitaros, a product candidate for the treatment of erectile dysfunction, were presented at the AUA annual meeting in San Diego. The analysis evaluated the safety and efficacy of Vitaros after 12 weeks, and longer term use, in men previously unresponsive to phosphodiesterase type-5 inhibitors. Results showed that 200-mcg and 300-mcg doses of Vitaros improved erections in this population, and adverse events were mild to moderate, similar to those seen in the control group, and decreased with repeated exposure, according to Apricus Biosciences, which is developing the drug.